GlassScriptPhysician profile
Usama Sadiq
NPI 1295390623
$7,602.83
in general payments reported to CMS, 2019-2025
13 companies · $6,390 in 2025
The $6,390 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $380 · 2023: $482 · 2024: $351 · 2025: $6,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $3,500 · Travel and Lodging: $1,501 · Food and Beverage: $1,490 · Education: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $3,500.00 |
| Travel and Lodging | $1,501.41 |
| Food and Beverage | $1,489.79 |
| Education | $731.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,959.03 | 2025 | Corevalve Evolut R, Resolute Onyx |
| Edwards Lifesciences Corporation | $2,127.58 | 2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $763.88 | 2022-2024 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit |
| Biotronik INC. | $288.28 | 2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Shockwave Medical, INC | $164.00 | 2022 | |
| Impulse Dynamics (USA) INC. | $55.00 | 2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.45 | 2023-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $45.63 | 2023-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $42.31 | 2023 | |
| Abiomed | $41.03 | 2023 | Impella |
| Actelion Pharmaceuticals US, INC. | $36.21 | 2023-2024 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals, LTD. | $18.57 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $14.86 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usama Sadiq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.